A study of a cohort of 333 primary prostate carcinomas showed that 74% of these tumors fell into one of seven subtypes of a molecular taxonomy defined by specific gene fusions (ERG,ETV1/4 and FLI1) or mutations (SPOP,FOXA1 and IDH1) [3]. This evidence concerns the gene FLI1 and prostate carcinoma.